January 30, 2018 / 9:10 PM / 3 months ago

BRIEF-Avexis To Initiate Screening For Remaining Patients In Pivotal Trial Of AVXS-101

Reuters Staff

1 Min Read

Jan 30 (Reuters) - Avexis Inc:

* AVEXIS TO INITIATE SCREENING FOR REMAINING PATIENTS IN PIVOTAL TRIAL OF AVXS-101 FOR SMA TYPE 1 FOLLOWING REVIEW OF PRELIMINARY DATA FROM FIRST THREE PATIENTS Source text for Eikon: Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.

0 : 0

narrow-browser-and-phone
medium-browser-and-portrait-tablet
landscape-tablet
medium-wide-browser
wide-browser-and-larger
medium-browser-and-landscape-tablet
medium-wide-browser-and-larger
above-phone
portrait-tablet-and-above
above-portrait-tablet
landscape-tablet-and-above
landscape-tablet-and-medium-wide-browser
portrait-tablet-and-below
landscape-tablet-and-below

All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.